Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release versus oxycodone prolonged-release for cancer pain
ChiCTR2600132789Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone + naloxone and oxycodone in cancer pain (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Brief Pain Inventory (BPI) at Week 12 and Bowel Function Index (BFI) at Week 12. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2600132789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132789.